Internet Archive Scholar

Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial

Bart Jan Kullberg, Claudio Viscoli, Peter G Pappas, Jose Vazquez, Luis Ostrosky-Zeichner, Coleman Rotstein, Jack D Sobel, Raoul Herbrecht, Galia Rahav, Sutep Jaruratanasirikul, Ploenchan Chetchotisakd, Eric Van Wijngaerden (+7 others)
2018 Clinical Infectious Diseases  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (816.3 kB)
https://web.archive.org/web/20210428125838/https://lirias2repo.kuleuven.be/bitstream/handle/123456789/628325/Isavuconazole%20versus%20Caspofungin%20in%20the%20Treatment%20of%20Candidemia%20and%20Other%20Invasive%20Candida%20Infections.pdf;jsessionid=B1046DA4B79F86FB49F2CD02176FB173?sequence=2

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

Isavuconazole was compared to caspofungin followed by oral voriconazole in a Phase 3, randomized, double-blind, multinational clinical trial for the primary treatment of patients with candidemia or invasive candidiasis.
doi:10.1093/cid/ciy827 pmid:30289478 fatcat:df3oxoc7vvavfeg2l7mvyhxv6y
Citation

Bart Jan Kullberg, Claudio Viscoli, Peter G Pappas, Jose Vazquez, Luis Ostrosky-Zeichner, Coleman Rotstein, Jack D Sobel, Raoul Herbrecht, Galia Rahav, Sutep Jaruratanasirikul, Ploenchan Chetchotisakd, Eric Van Wijngaerden, Jan De Waele, Christopher Lademacher, Marc Engelhardt, Laura Lynn Kovanda, Rodney Croos-Dabrera, Christine Fredericks, George R Thompson. "Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial." Clinical Infectious Diseases 68.12 (2018) 1981-1989